retatrutide trial data Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Eli Lilly Obesity Drug Market

Are there any side effects to taking glutathione orally

Anti-aging research with GHK-Cu extends far beyond skin cosmetics

Creatine supplementation is showing promise in this area

Designed as a weekly injection, Mounjaro offers convenient support for weight management

Interstate Medical Licensure Compact (IMLC) : Physicians in compact states can more easily obtain licenses in other compact states

Central prolactin infusion in rats increases food intake, but prolactin receptor knockout mice show reduced adiposity and prolactin deficiency had only negligible effects on body weight, body composition, serum lipids and adiponectin concentrations (63, 64)